Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 222

1.

Increasing Fat Graft Retention in Irradiated Tissue After Preconditioning with External Volume Expansion."

Lujan-Hernandez J, Chin MS, Perry DJ, Chappell A, Lancerotto L, Yu N, Slamin RP, Bannon E, Fitzgerald TJ, Lalikos JF.

Plast Reconstr Surg. 2019 Sep 30. doi: 10.1097/PRS.0000000000006372. [Epub ahead of print]

PMID:
31577660
2.

The VEGF receptor neuropilin 2 promotes homologous recombination by stimulating YAP/TAZ-mediated Rad51 expression.

Elaimy AL, Amante JJ, Zhu LJ, Wang M, Walmsley CS, FitzGerald TJ, Goel HL, Mercurio AM.

Proc Natl Acad Sci U S A. 2019 Jul 9;116(28):14174-14180. doi: 10.1073/pnas.1821194116. Epub 2019 Jun 24.

PMID:
31235595
3.

Open access image repositories: high-quality data to enable machine learning research.

Prior F, Almeida J, Kathiravelu P, Kurc T, Smith K, Fitzgerald TJ, Saltz J.

Clin Radiol. 2019 Apr 27. pii: S0009-9260(19)30169-2. doi: 10.1016/j.crad.2019.04.002. [Epub ahead of print]

PMID:
31040006
4.

An in-silico quality assurance study of contouring target volumes in thoracic tumors within a cooperative group setting.

Elhalawani H, Elgohari B, Lin TA, Mohamed ASR, Fitzgerald TJ, Laurie F, Ulin K, Kalpathy-Cramer J, Guerrero T, Holliday EB, Russo G, Patel A, Jones W, Walker GV, Awan M, Choi M, Dagan R, Mahmoud O, Shapiro A, Kong FS, Gomez D, Zeng J, Decker R, Spoelstra FOB, Gaspar LE, Kachnic LA, Thomas CR Jr, Okunieff P, Fuller CD.

Clin Transl Radiat Oncol. 2019 Jan 6;15:83-92. doi: 10.1016/j.ctro.2019.01.001. eCollection 2019 Feb.

5.

Optimisation of adaptive therapy for advanced Hodgkin lymphoma.

Fitzgerald TJ.

Lancet Oncol. 2019 Feb;20(2):167-168. doi: 10.1016/S1470-2045(19)30005-1. Epub 2019 Jan 15. No abstract available.

PMID:
30658934
6.

The Importance of Imaging in Radiation Oncology for National Clinical Trials Network Protocols.

FitzGerald TJ, Bishop-Jodoin M, Laurie F, O'Meara E, Davis C, Bogart J, Kalapurakal J, Siegel MJ, Chakravarthy B, Okunieff P, Haffty B, Michalski J, Ulin K, Followill DS, Kry S, Knopp M, Zhang J, Rosen D, Rosen M, Xiao Y, Schwartz L, Moni J, Cicchetti MG.

Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):775-782. doi: 10.1016/j.ijrobp.2018.08.039. Epub 2018 Oct 18. Review.

PMID:
30353882
7.

The Influence of Imaging in the Modern Practice of Radiation Oncology.

FitzGerald TJ, Rosen MA, Bishop-Jodoin M.

Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):680-682. doi: 10.1016/j.ijrobp.2018.08.028. Epub 2018 Oct 18. No abstract available.

PMID:
30353876
8.

αvβ3 Integrin Mediates Radioresistance of Prostate Cancer Cells through Regulation of Survivin.

Wang T, Huang J, Vue M, Alavian MR, Goel HL, Altieri DC, Languino LR, FitzGerald TJ.

Mol Cancer Res. 2019 Feb;17(2):398-408. doi: 10.1158/1541-7786.MCR-18-0544. Epub 2018 Sep 28.

PMID:
30266752
9.

Preoperative Intensity Modulated Radiation Therapy Compared to Three-Dimensional Conformal Radiation Therapy for High-Grade Extremity Sarcomas in Children: Analysis of the Children's Oncology Group Study ARST0332.

Rao AD, Chen Q, Million L, Spunt SL, Fitzgerald TJ, Hu C, Rao SS, Laurie F, Kessel S, Morano K, Ladra MM, Terezakis SA.

Int J Radiat Oncol Biol Phys. 2019 Jan 1;103(1):38-44. doi: 10.1016/j.ijrobp.2018.09.005. Epub 2018 Sep 10.

PMID:
30213752
10.

Cardiac-Sparing Whole Lung IMRT in Patients With Pediatric Tumors and Lung Metastasis: Final Report of a Prospective Multicenter Clinical Trial.

Kalapurakal JA, Gopalakrishnan M, Walterhouse DO, Rigsby CK, Rademaker A, Helenowski I, Kessel S, Morano K, Laurie F, Ulin K, Esiashvili N, Katzenstein H, Marcus K, Followill DS, Wolden SL, Mahajan A, Fitzgerald TJ.

Int J Radiat Oncol Biol Phys. 2019 Jan 1;103(1):28-37. doi: 10.1016/j.ijrobp.2018.08.034. Epub 2018 Aug 29.

PMID:
30170102
11.

Feasibility and accuracy of UF/NCI phantoms and Monte Carlo retrospective dosimetry in children treated on National Wilms Tumor Study protocols.

Kalapurakal JA, Gopalakrishnan M, Mille M, Helenowski I, Peterson S, Rigsby C, Laurie F, Jung JW, Fitzgerald TJ, Lee C.

Pediatr Blood Cancer. 2018 Dec;65(12):e27395. doi: 10.1002/pbc.27395. Epub 2018 Aug 12.

PMID:
30101560
12.

The Children's Oncology Group Radiation Oncology Discipline: 15 Years of Contributions to the Treatment of Childhood Cancer.

Breneman JC, Donaldson SS, Constine L, Merchant T, Marcus K, Paulino AC, Followill D, Mahajan A, Laack N, Esiashvili N, Haas-Kogan D, Laurie F, Olch A, Ulin K, Hodgson D, Yock TI, Terezakis S, Krasin M, Panoff J, Chuba P, Hua CH, Hess CB, Houghton PJ, Wolden S, Buchsbaum J, Fitzgerald TJ, Kalapurakal JA.

Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):860-874. doi: 10.1016/j.ijrobp.2018.03.002. Epub 2018 Mar 14. Review.

13.

The Role of Race and Economic Characteristics in the Presentation and Survival of Patients With Surgically Resected Non-Small Cell Lung Cancer.

Varlotto JM, McKie K, Voland RP, Flickinger JC, DeCamp MM, Maddox D, Rava PS, Fitzgerald TJ, Walsh W, Oliveira P, Rassaei N, Baima J, Uy K.

Front Oncol. 2018 May 14;8:146. doi: 10.3389/fonc.2018.00146. eCollection 2018.

14.

Patterns of Involved-Field Radiation Therapy Protocol Deviations in Pediatric Versus Adolescent and Young Adults With Hodgkin Lymphoma: A Report From the Children's Oncology Group AHOD0031.

Parzuchowski A, Bush R, Pei Q, Friedman DL, FitzGerald TJ, Wolden SL, Dharmarajan KV, Constine LS, Laurie F, Kessel SK, Appel B, Fernandez K, Punnett A, Schwartz CL, Cox J, Terezakis SA.

Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1119-1125. doi: 10.1016/j.ijrobp.2018.01.002. Epub 2018 Jan 6.

15.

Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017.

Okunieff P, Casey-Sawicki K, Lockney NA, Hoppe BS, Enderling H, Pinnix C, Welsh J, Krishnan S, Yothers G, Brown M, Knox S, Bristow R, Spellman P, Mitin T, Nabavizadeh N, Jaboin J, Manning HC, Feng F, Galbraith S, Solanki AA, Harkenrider MM, Tuli R, Decker RH, Finkelstein SE, Hsu CC, Ha CS, Jagsi R, Shumway D, Daly M, Wang TJC, Fitzgerald TJ, Laurie F, Marshall DT, Raben D, Constine L, Thomas CR Jr, Kachnic LA.

Clin Cancer Res. 2018 Aug 1;24(15):3500-3509. doi: 10.1158/1078-0432.CCR-17-3202. Epub 2018 Apr 16.

16.

Association between cumulative radiation dose, adverse skin reactions, and changes in surface hemoglobin among women undergoing breast conserving therapy.

Chin MS, Siegel-Reamer L, FitzGerald GA, Wyman A, Connor NM, Lo YC, Sioshansi S, Moni J, Giulia Cicchetti M, Lalikos JF, FitzGerald TJ.

Clin Transl Radiat Oncol. 2017 May 18;4:15-23. doi: 10.1016/j.ctro.2017.03.003. eCollection 2017 Jun.

17.

Population-based differences in the outcome and presentation of lung cancer patients based upon racial, histologic, and economic factors in all lung patients and those with metastatic disease.

Varlotto JM, Voland R, McKie K, Flickinger JC, DeCamp MM, Maddox D, Rava P, Fitzgerald TJ, Graeber G, Rassaei N, Oliveira P, Ali S, Belani C, Glanzman J, Wakelee HA, Patel M, Baima J, Zhang J, Walsh W.

Cancer Med. 2018 Apr;7(4):1211-1220. doi: 10.1002/cam4.1430. Epub 2018 Mar 13.

18.

American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology.

Mayo CS, Moran JM, Bosch W, Xiao Y, McNutt T, Popple R, Michalski J, Feng M, Marks LB, Fuller CD, Yorke E, Palta J, Gabriel PE, Molineu A, Matuszak MM, Covington E, Masi K, Richardson SL, Ritter T, Morgas T, Flampouri S, Santanam L, Moore JA, Purdie TG, Miller RC, Hurkmans C, Adams J, Jackie Wu QR, Fox CJ, Siochi RA, Brown NL, Verbakel W, Archambault Y, Chmura SJ, Dekker AL, Eagle DG, Fitzgerald TJ, Hong T, Kapoor R, Lansing B, Jolly S, Napolitano ME, Percy J, Rose MS, Siddiqui S, Schadt C, Simon WE, Straube WL, St James ST, Ulin K, Yom SS, Yock TI.

Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):1057-1066. doi: 10.1016/j.ijrobp.2017.12.013. Epub 2017 Dec 15. Review.

19.

Development and pilot testing of a text message vaccine reminder system for use during an influenza pandemic.

Lehnert JD, Shevach A, Walker S, Wang R, Fitzgerald TJ, Graitcer SB.

Hum Vaccin Immunother. 2018 Jul 3;14(7):1647-1653. doi: 10.1080/21645515.2018.1440162. Epub 2018 Apr 9.

20.

Hodgkin Lymphoma: Differences in Treatment Between Europe and the United States/North America: Evolving Trends in Protocol Therapy.

FitzGerald TJ, Bishop-Jodoin M.

Clin Med Insights Oncol. 2018 Jan 31;12:1179554918754885. doi: 10.1177/1179554918754885. eCollection 2018. Review.

21.

Dual radiosensitization and anti-STAT3 anti-proliferative strategy based on delivery of gold nanoparticle - oligonucleotide nanoconstructs to head and neck cancer cells.

Zhang S, Gupta S, Fitzgerald TJ, Bogdanov AA Jr.

Nanotheranostics. 2018 Jan 1;2(1):1-11. doi: 10.7150/ntno.22335. eCollection 2018.

22.

Potential Role of the Quality Assurance Review Center Platform in Global Radiation Oncology.

Ngwa W, Ikhile E, Ntekim A, Lasebikan N, Alabi A, Shagaya UN, Omolara F, Ali-Gombe M, Bojude AD, Ngoma M, Ngoma T, Bhagwat M, Irabor OC, Schoenfeld J, Nguyen P, Sajo E, Laurie F, Moni J, Fitzgerald TJ.

Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):956-962. doi: 10.1016/j.ijrobp.2017.06.2461. No abstract available.

PMID:
29063855
23.

2015 Pandemic Influenza Readiness Assessment Among US Public Health Emergency Preparedness Awardees.

Fitzgerald TJ, Moulia DL, Graitcer SB, Vagi SJ, Dopson SA.

Am J Public Health. 2017 Sep;107(S2):S177-S179. doi: 10.2105/AJPH.2017.303952.

24.

Readiness to Vaccinate Critical Personnel During an Influenza Pandemic, United States, 2015.

Moulia DL, Dopson SA, Vagi SJ, Fitzgerald TJ, Fiebelkorn AP, Graitcer SB.

Am J Public Health. 2017 Oct;107(10):1643-1645. doi: 10.2105/AJPH.2017.303942. Epub 2017 Aug 17.

25.

Conventional Radiation Therapy Compared With Stereotactic Conformal Therapy-A Rare and Laudable Randomized Trial.

Mendenhall NP, Fitzgerald TJ.

JAMA Oncol. 2017 Oct 1;3(10):1376-1377. doi: 10.1001/jamaoncol.2017.1552. No abstract available.

PMID:
28570720
26.

Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205).

Garg MK, Zhao F, Sparano JA, Palefsky J, Whittington R, Mitchell EP, Mulcahy MF, Armstrong KI, Nabbout NH, Kalnicki S, El-Rayes BF, Onitilo AA, Moriarty DJ, Fitzgerald TJ, Benson AB 3rd.

J Clin Oncol. 2017 Mar;35(7):718-726. doi: 10.1200/JCO.2016.69.1667. Epub 2017 Jan 9.

27.

Cetuximab Plus Chemoradiotherapy for HIV-Associated Anal Carcinoma: A Phase II AIDS Malignancy Consortium Trial.

Sparano JA, Lee JY, Palefsky J, Henry DH, Wachsman W, Rajdev L, Aboulafia D, Ratner L, Fitzgerald TJ, Kachnic L, Mitsuyasu R.

J Clin Oncol. 2017 Mar;35(7):727-733. doi: 10.1200/JCO.2016.69.1642. Epub 2016 Dec 12.

28.

Effect of Standard Radiotherapy With Cisplatin vs Accelerated Radiotherapy With Panitumumab in Locoregionally Advanced Squamous Cell Head and Neck Carcinoma: A Randomized Clinical Trial.

Siu LL, Waldron JN, Chen BE, Winquist E, Wright JR, Nabid A, Hay JH, Ringash J, Liu G, Johnson A, Shenouda G, Chasen M, Pearce A, Butler JB, Breen S, Chen EX, FitzGerald TJ, Childs TJ, Montenegro A, O'Sullivan B, Parulekar WR.

JAMA Oncol. 2017 Feb 1;3(2):220-226. doi: 10.1001/jamaoncol.2016.4510.

PMID:
27930762
29.

Integrating pharmacies into public health program planning for pandemic influenza vaccine response.

Fitzgerald TJ, Kang Y, Bridges CB, Talbert T, Vagi SJ, Lamont B, Graitcer SB.

Vaccine. 2016 Nov 4;34(46):5643-5648. doi: 10.1016/j.vaccine.2016.09.020. Epub 2016 Sep 26.

30.

Reply: External Volume Expansion in Irradiated Tissue: Effects on the Recipient Site.

Chin MS, Lujan-Hernandez J, Babchenko O, Bannon E, Perry DJ, Chappell AG, Lo YC, Fitzgerald TJ, Lalikos JF.

Plast Reconstr Surg. 2017 Jan;139(1):314e-315e. doi: 10.1097/PRS.0000000000002872. No abstract available.

PMID:
27632403
31.

αvβ6 Integrin Promotes Castrate-Resistant Prostate Cancer through JNK1-Mediated Activation of Androgen Receptor.

Lu H, Wang T, Li J, Fedele C, Liu Q, Zhang J, Jiang Z, Jain D, Iozzo RV, Violette SM, Weinreb PH, Davis RJ, Gioeli D, FitzGerald TJ, Altieri DC, Languino LR.

Cancer Res. 2016 Sep 1;76(17):5163-74. doi: 10.1158/0008-5472.CAN-16-0543. Epub 2016 Jul 22.

32.

External Volume Expansion in Irradiated Tissue: Effects on the Recipient Site.

Chin MS, Lujan-Hernandez J, Babchenko O, Bannon E, Perry DJ, Chappell AG, Lo YC, Fitzgerald TJ, Lalikos JF.

Plast Reconstr Surg. 2016 May;137(5):799e-807e. doi: 10.1097/PRS.0000000000002081.

PMID:
27119942
33.

A Comparative Evaluation of Normal Tissue Doses for Patients Receiving Radiation Therapy for Hodgkin Lymphoma on the Childhood Cancer Survivor Study and Recent Children's Oncology Group Trials.

Zhou R, Ng A, Constine LS, Stovall M, Armstrong GT, Neglia JP, Friedman DL, Kelly K, FitzGerald TJ, Hodgson DC.

Int J Radiat Oncol Biol Phys. 2016 Jun 1;95(2):707-11. doi: 10.1016/j.ijrobp.2016.01.053. Epub 2016 Feb 4.

34.

Imaging and Data Acquisition in Clinical Trials for Radiation Therapy.

FitzGerald TJ, Bishop-Jodoin M, Followill DS, Galvin J, Knopp MV, Michalski JM, Rosen MA, Bradley JD, Shankar LK, Laurie F, Cicchetti MG, Moni J, Coleman CN, Deye JA, Capala J, Vikram B.

Int J Radiat Oncol Biol Phys. 2016 Feb 1;94(2):404-11. doi: 10.1016/j.ijrobp.2015.10.028. Epub 2015 Oct 24. Review.

35.

Hyperspectral Imaging as an Early Biomarker for Radiation Exposure and Microcirculatory Damage.

Chin MS, Freniere BB, Lancerotto L, Lujan-Hernandez J, Saleeby JH, Lo YC, Orgill DP, Lalikos JF, Fitzgerald TJ.

Front Oncol. 2015 Oct 26;5:232. doi: 10.3389/fonc.2015.00232. eCollection 2015.

36.

Distinguishing grade I meningioma from higher grade meningiomas without biopsy.

Varlotto J, Flickinger J, Pavelic MT, Specht CS, Sheehan JM, Timek DT, Glantz MJ, Sogge S, Dimaio C, Moser R, Yunus S, Fitzgerald TJ, Upadhyay U, Rava P, Tangel M, Yao A, Kanekar S.

Oncotarget. 2015 Nov 10;6(35):38421-8. doi: 10.18632/oncotarget.5376.

37.

A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Combination of Bevacizumab (NSC-704865) in Patients With Inoperable Locally Advanced Stage III Non-Small-Cell Lung Cancer: SWOG S0533.

Wozniak AJ, Moon J, Thomas CR Jr, Kelly K, Mack PC, Gaspar LE, Raben D, Fitzgerald TJ, Pandya KJ, Gandara DR.

Clin Lung Cancer. 2015 Sep;16(5):340-7. doi: 10.1016/j.cllc.2014.12.014. Epub 2015 Jan 9.

38.

Radiotherapy quality assurance report from children's oncology group AHOD0031.

Dharmarajan KV, Friedman DL, FitzGerald TJ, McCarten KM, Constine LS, Chen L, Kessel SK, Iandoli M, Laurie F, Schwartz CL, Wolden SL.

Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):1065-71. doi: 10.1016/j.ijrobp.2014.11.034. Epub 2015 Feb 7.

39.

Patterns of relapse from a phase 3 Study of response-based therapy for intermediate-risk Hodgkin lymphoma (AHOD0031): a report from the Children's Oncology Group.

Dharmarajan KV, Friedman DL, Schwartz CL, Chen L, FitzGerald TJ, McCarten KM, Kessel SK, Iandoli M, Constine LS, Wolden SL.

Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):60-6. doi: 10.1016/j.ijrobp.2014.10.042. Epub 2014 Dec 24.

40.

The impact of protocol assignment for older adolescents with hodgkin lymphoma.

Pieters RS, Wagner H, Baker S, Morano K, Ulin K, Cicchetti MG, Bishop-Jodoin M, FitzGerald TJ.

Front Oncol. 2014 Nov 28;4:317. doi: 10.3389/fonc.2014.00317. eCollection 2014.

41.

Dosimetric impact of the AeroForm tissue expander in postmastectomy radiation therapy: an ex vivo analysis.

Moni J, Saleeby J, Bannon E, Lo YC, Fitzgerald TJ.

Pract Radiat Oncol. 2015 Jan-Feb;5(1):e1-8. doi: 10.1016/j.prro.2014.04.001. Epub 2014 May 28.

PMID:
25413421
42.

Diaphragm injury after liver stereotactic body radiation therapy.

Sioshansi S, Rava PS, Karam AR, Lithgow M, Ding L, Xing W, FitzGerald TJ.

Pract Radiat Oncol. 2014 Nov-Dec;4(6):e227-30. doi: 10.1016/j.prro.2014.01.001. Epub 2014 Feb 18. No abstract available.

PMID:
25407873
43.

Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031.

Friedman DL, Chen L, Wolden S, Buxton A, McCarten K, FitzGerald TJ, Kessel S, De Alarcon PA, Chen AR, Kobrinsky N, Ehrlich P, Hutchison RE, Constine LS, Schwartz CL.

J Clin Oncol. 2014 Nov 10;32(32):3651-8. doi: 10.1200/JCO.2013.52.5410. Epub 2014 Oct 13.

44.

Bending the cost curve: a unique collaboration between radiation oncologists and Blue Cross Blue Shield of Massachusetts to optimize the use of advanced technology.

Steingisser L, Acker B, Berman S, Brenner MJ, Bornstein BA, Busse P, FitzGerald TJ, Jacobson JO, Jekowsky E, Kachnic LA, Mamon H, McKee A, Shulman LN, Stevenson MA, Wazer D, Fallon JA.

J Oncol Pract. 2014 Sep;10(5):e321-7. doi: 10.1200/JOP.2014.001473.

PMID:
25232190
45.

SBRT Using Residual Lipiodol as Surrogate Fiducial for Image Guidance in the Treatment of Recurrent or Residual Hepatocellular Carcinoma.

Sioshansi S, Ding L, Fitzgerald TJ.

Pract Radiat Oncol. 2013 Apr-Jun;3(2 Suppl 1):S17. doi: 10.1016/j.prro.2013.01.061. Epub 2013 Mar 25. No abstract available.

PMID:
24674498
46.

A new model for imaging and radiation therapy quality assurance in the National Clinical Trials Network of the National Cancer Institute.

FitzGerald TJ.

Int J Radiat Oncol Biol Phys. 2014 Feb 1;88(2):272-3. doi: 10.1016/j.ijrobp.2013.09.030. No abstract available.

PMID:
24411600
47.

Integrin αvβ6 promotes an osteolytic program in cancer cells by upregulating MMP2.

Dutta A, Li J, Lu H, Akech J, Pratap J, Wang T, Zerlanko BJ, FitzGerald TJ, Jiang Z, Birbe R, Wixted J, Violette SM, Stein JL, Stein GS, Lian JB, Languino LR.

Cancer Res. 2014 Mar 1;74(5):1598-608. doi: 10.1158/0008-5472.CAN-13-1796. Epub 2014 Jan 2.

48.

A Phase II Trial of Cetuximab, Gemcitabine, 5-Fluorouracil, and Radiation Therapy in Locally Advanced Nonmetastatic Pancreatic Adenocarcinoma.

Cetin V, Piperdi B, Bathini V, Walsh WV, Yunus S, Tseng JF, Whalen GF, Wassef WY, Kadish SP, Fitzgerald TJ, Mikule C, Wang Y, Grossman SR.

Gastrointest Cancer Res. 2013 Jul;6(4 Suppl 1):S2-9.

49.

Skin perfusion and oxygenation changes in radiation fibrosis.

Chin MS, Freniere BB, Bonney CF, Lancerotto L, Saleeby JH, Lo YC, Orgill DP, Fitzgerald TJ, Lalikos JF.

Plast Reconstr Surg. 2013 Apr;131(4):707-16. doi: 10.1097/PRS.0b013e3182818b94.

PMID:
23542244
50.

Future vision for the quality assurance of oncology clinical trials.

Fitzgerald TJ, Bishop-Jodoin M, Bosch WR, Curran WJ, Followill DS, Galvin JM, Hanusik R, King SR, Knopp MV, Laurie F, O'Meara E, Michalski JM, Saltz JH, Schnall MD, Schwartz L, Ulin K, Xiao Y, Urie M.

Front Oncol. 2013 Mar 15;3:31. doi: 10.3389/fonc.2013.00031. eCollection 2013.

Supplemental Content

Loading ...
Support Center